News

 
Following are announcements of notable deals and cases on which Davis Polk has advised, as well as a range of other news items about the firm and our lawyers. 
April 12, 2021 Marvell Technology $2 billion senior notes offering
We advised the initial purchasers on the unregistered debt offering
April 12, 2021 Ionis Pharmaceuticals $632.5 million convertible senior notes offering
We advised the purchasers on the Rule 144A convertible notes offering
April 12, 2021 Maravai LifeSciences $646.9 million secondary offering
We advised the joint book-running managers on the equity offering
April 7, 2021 Frontier $655.5 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
April 7, 2021 Lightyear Capital to sell Therapy Brands to KKR
We advised Lightyear Capital on the sale
April 6, 2021 Open Lending $351.9 million secondary offering
We advised the underwriters in connection with the equity offering
April 1, 2021 YUM! Brands $1.1 billion senior notes offering
We advised the underwriters on the high-yield debt offering
April 1, 2021 Beam Therapeutics $300 million at-the-market offering
We advised the sales agent in connection with the equity offering
March 31, 2021 Bridgepoint acquisition of Sun World International
We are advising Bridgepoint on the acquisition
March 30, 2021 LAVA Therapeutics $100.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing

News

News Search: